HIV infection and cancer in the era of highly active antiretroviral therapy (Review)

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1121-1126

  Barbaro, Giuseppe ^a   Barbarini, Giorgio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Acquired immunodeficiency syndrome; Cancer; Highly active antiretroviral therapy; Human immunodeficiency virus

Indexed keywords

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEOPLASM; REVIEW; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HUMANS; NEOPLASMS;

EID: 34548591679     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1121     Document Type: Review

References (44)

1. Newcomb-Fernandez J: Cancer in the HIV-infected population. Res Initiat Treat Action 9: 5-13, 2003.
2. Goedert JJ, Cotè TR, Virgo P, et al: Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833-1839, 1998. (Pubitemid 28279706)
3. Frisch M, Biggar RJ, Engels EA, Goedert JJ for the AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285: 1736-1745, 2001. (Pubitemid 32259908)
4. Gallagher B, Wang Z, Schymura MJ, Kahn A and Fordyce EJ: Cancer incidence in New York State Acquired Immunodeficiency Syndrome patients. Am J Epidemiol 154: 544-556, 2001. (Pubitemid 32867954)
5. Spano JP, Atlan D, Breau JL and Farge D: AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part I: Kaposi's sarcoma, and Hodgkin's lymphoma. Eur J Int Med 13: 170-179, 2002. (Pubitemid 34518507)
6. Mbulaiteye SM, Biggar RJ, Goedert JJ and Engels EA: Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32: 527-533, 2003. (Pubitemid 36423125)
7. Gates AE and Kaplan LD: AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16: 441-459, 2002.
8. Rabkin CS: AIDS and cancer in the era of highly active antiretroviral therapy (HAART). Eur J Cancer 37: 1316-1319, 2001.
9. International Collaboration on HIV and Cancer: Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92: 1823-1830, 2000.
10. Portsmouth S, Stebbing J, Gill J, et al: A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 17: F17-F22, 2003. (Pubitemid 36951678)
11. Carrieri MP, Pradier C, Piselli P, et al: Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer 103: 142-144, 2002.
12. Louie JK, Hsu LC, Osmond DH, Katz MH and Schwarcz SK: Trends in causes of death among persons with Acquired Immunodeficiency Syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 186: 1023-1027, 2002.
13. Dal Maso L and Franceschi S: Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 4: 110-119, 2003. (Pubitemid 36193171)
14. Hoffmann C, Wolf E, Fatkenheuer G, et al: Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 17: 1521-1529, 2003. (Pubitemid 36900553)
15. Gates AE and Kaplan LD: AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16: 657-665, 2002.
16. Clayton A and Mughal T: The changing face of HIV-associated lymphoma: what can we learn about optimal therapy in the post highly active antiretroviral therapy era? Hematol Oncol 22: 111-120, 2004. (Pubitemid 40990932)
17. Skiest DJ and Crosby C: Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary nervous system lymphoma. AIDS 17: 1787-1793, 2003. (Pubitemid 37000096)
18. Hoffmann C, Chow KU, Wolf E, et al: Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 125: 455-462, 2004. (Pubitemid 38916190)
19. Phelps RM, Smith DK, Heilig CM, et al. Cancer incidence in women with or at risk for HIV. Int J Cancer 94: 753-757, 2001. (Pubitemid 33035698)
20. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R and Gates EJ: Cervical cancer as an AIDS defining illness. Obstet Gynecol 89: 76-80, 1997. (Pubitemid 27024471)
21. Delmas MC, Larsen C, van Benthem B, et al: Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS 14: 1775-1784, 2000.
22. Clarke B and Chetty R: Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 55: 19-24, 2002. (Pubitemid 34123926)
23. Robinson WR, Luck MB, Kendall MA and Darragh TM: The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: a substudy of a randomized, phase III chemoprevention trial. Am J Obstet Gynecol 188: 896-900, 2003.
24. de Sanjosè S and Palefsky J: Cervical and anal HPV infection in HIV positive women and men. Virus Res 89: 210-211, 2002.
25. Minkoff H, Ahdieh L, Massad LS, et al: The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15: 2157-2164, 2001. (Pubitemid 33101823)
26. Heard I, Tassie JM, Kazatchkine MD and Orth G: Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 16: 1799-1802, 2002.
27. Lillo FB, Ferrari D, Veglia F, et al: Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 184: 547-551, 2001. (Pubitemid 32783544)
28. Grulich AE, Li Y, McDonald A, Correll PKL, Law MG and Kaldor JM: Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16: 1155-1161, 2002. (Pubitemid 34533854)
29. Vilchez RA, Finch CJ, Jorgensen JL and Butel JS: The clinical epidemiology of Hodgkin lymphoma in HIV infected patients in the highly active antiretroviral therapy (HAART) era. Medicine 82: 77-81, 2003. (Pubitemid 36331638)
30. Piketty C, Darragh TM, Da Costa M, et al: High prevalence of anal human Papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 138: 453-459, 2003.
31. Spano JP, Atlan D, Breau JL and Farge D: AIDS and non-AIDS related malignancies: a new vexing challenge in HIV-positive patients. Part II. Cervical and anal squamous epithelial lesions, lung cancer, testicular germ cell cancers and skin cancers. Eur J Int Med 13: 227-232, 2002. (Pubitemid 34627051)
32. Palefsky J: Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection. J Acquir Immune Defic Syndr 21 (suppl 1): S42-S48, 1999.
33. Palefsky JM, Holly EA, Ralston ML, Da Costa M and Greenblatt RM: Prevalence and risk factors for anal Papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 183: 383-391, 2001. (Pubitemid 32105597)
34. Bower M, Powles T, Newsom-Davis T, et al: HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 37: 1563-1565, 2004. (Pubitemid 39658192)
35. Tirelli U, Spina M, Sandri S, et al: Lung carcinoma in 36 patients with human immunodeficiency virus infection. Cancer 88: 563-569, 2000. (Pubitemid 30056930)
36. Bower M, Powles T, Nelson M, et al: HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 17: 371-375, 2003. (Pubitemid 36230918)
37. Powles T, Bower M, Daugaard G, et al: Multicenter study of human immunodeficiency virus-related germ cell tumors. J Clin Oncol 21: 1922-1927, 2003. (Pubitemid 46606379)
38. Fizazi K, Amato RJ, Beuzeboc P, et al: Germ cell tumors in patients infected by the human immunodeficiency virus. Cancer 92: 1460-1467, 2001. (Pubitemid 32947830)
39. Crum N, Hale U, Utz G and Wallace M: Increased risk of prostate cancer in HIV infection? AIDS 16: 1703-1704, 2002. (Pubitemid 34921125)
40. Demopoulos BP, Vamvakas E, Ehrlich JE and Demopoulos R: Non-Acquired Immunodeficiency Syndrome-defining malignancies in patients infected with Human Immunodeficiency Virus. Arch Path Lab Med 127: 589-592, 2003. (Pubitemid 36534944)
41. Clarke CA and Glaser SL: Epidemiologic trends in HIV-associated lymphomas. Curr Opin Oncol 13: 354-359, 2001. (Pubitemid 32785293)
42. El-Rayes BF, Berenij K, Schuman P and Philip PA: Breast cancer in women with human immunodeficiency virus infection: implications for diagnosis and therapy. Breast Cancer Res Treat 76: 111-116, 2002. (Pubitemid 35252487)
43. Ratner L, Lee J, Tang S, et al: Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19: 2171-2178, 2001. (Pubitemid 32366971)
44. Little RF, Pittaluga S, Grant N, et al: Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101: 4653-4659, 2003. (Pubitemid 36857717)